NATH BIOGENES (INDIA)
Quarterly Results Analysis [Sep2024]
NATH BIOGENES (INDIA) Quarterly Results
Consolidated | Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹32 Cr | ₹244 Cr | ₹43 Cr | ₹32 Cr | ₹23 Cr | ₹235 Cr | ₹45 Cr | ₹25 Cr |
Expenses | ₹27 Cr | ₹207 Cr | ₹39 Cr | ₹26 Cr | ₹18 Cr | ₹198 Cr | ₹41 Cr | ₹20 Cr |
Operating Income | ₹5 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹1 Cr | ₹34 Cr | ₹2 Cr | ₹5 Cr | ₹2 Cr | ₹33 Cr | ₹2 Cr | ₹2 Cr |
Profit After Tax | ₹1 Cr | ₹33 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹33 Cr | ₹1 Cr | ₹1 Cr |
EPS | ₹0.59 | ₹17.55 | ₹1.38 | ₹2.01 | ₹0.80 | ₹17.47 | ₹0.76 | ₹0.71 |
Industry Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | -1.4% | -12.9% | -14% |
BOMBAY BURMAH TRADING CORPORATION | -3.9% | -6.7% | 67.7% |
KAVERI SEED COMPANY | -4% | -4.8% | 38.4% |
VENKYS (INDIA) | -1.3% | -1.2% | -15.9% |
BOMBAY SUPER HYBRID SEEDS | -7.3% | -13.4% | -38.7% |
TIERRA AGROTECH | 1.3% | -1.2% | -39.4% |
INDO US BIOTECH | -3.1% | -0.8% | 16.5% |
MANGALAM SEEDS | -12.1% | -13.4% | -8.9% |
SHREE OSWAL SEEDS AND CHEMICALS | -10.3% | -15.7% | -61.3% |
NATH BIOGENES (INDIA) Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -86.80 % |
Y-o-Y | 42.65 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹32 Cr | -86.80 | |
Jun2024 | ₹244 Cr | 466.65 | |
Mar2024 | ₹43 Cr | 35.60 | |
Dec2023 | ₹32 Cr | 40.63 | |
Sep2023 | ₹23 Cr | -90.41 | |
Jun2023 | ₹235 Cr | 422.99 | |
Mar2023 | ₹45 Cr | 77.84 | |
Dec2022 | ₹25 Cr | - |
NATH BIOGENES (INDIA) Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -86.83 % |
Y-o-Y | -3.37 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹5 Cr | -86.83 | |
Jun2024 | ₹37 Cr | 830.12 | |
Mar2024 | ₹4 Cr | -30.43 | |
Dec2023 | ₹6 Cr | 13.35 | |
Sep2023 | ₹5 Cr | -86.47 | |
Jun2023 | ₹37 Cr | 835.19 | |
Mar2023 | ₹4 Cr | -29.90 | |
Dec2022 | ₹6 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.20 % |
Y-o-Y | -32.26 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 14.95% | -0.20 | |
Jun2024 | 14.98% | 64.07 | |
Mar2024 | 9.13% | -48.68 | |
Dec2023 | 17.79% | -19.39 | |
Sep2023 | 22.07% | 41.11 | |
Jun2023 | 15.64% | 78.74 | |
Mar2023 | 8.75% | -60.59 | |
Dec2022 | 22.2% | - |
NATH BIOGENES (INDIA) Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -96.66 % |
Y-o-Y | -25.78 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹1 Cr | -96.66 | |
Jun2024 | ₹33 Cr | 1,897.25 | |
Mar2024 | ₹2 Cr | -56.27 | |
Dec2023 | ₹4 Cr | 154.43 | |
Sep2023 | ₹2 Cr | -95.48 | |
Jun2023 | ₹33 Cr | 2,207.51 | |
Mar2023 | ₹1 Cr | 6.60 | |
Dec2022 | ₹1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -74.71 % |
Y-o-Y | -47.97 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 3.46 % | -74.71 | |
Jun2024 | 13.68 % | 252.58 | |
Mar2024 | 3.88 % | -67.75 | |
Dec2023 | 12.03 % | 80.90 | |
Sep2023 | 6.65 % | -52.84 | |
Jun2023 | 14.1 % | 340.63 | |
Mar2023 | 3.2 % | -39.96 | |
Dec2022 | 5.33 % | - |
NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -96.64 % |
Y-o-Y | -26.25 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹0.59 | -96.64 | |
Jun2024 | ₹17.55 | 1,171.74 | |
Mar2024 | ₹1.38 | -31.34 | |
Dec2023 | ₹2.01 | 151.25 | |
Sep2023 | ₹0.8 | -95.42 | |
Jun2023 | ₹17.47 | 2,198.68 | |
Mar2023 | ₹0.76 | 7.04 | |
Dec2022 | ₹0.71 | - |
You may also like the below Video Courses
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs INDO US BIOTECH LTD